BioNTech SE Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,687	3,055	2,892	3,924	17,311	18,977
Revenue Growth (YoY)	4.82%	5.63%	-26.31%	-77.33%	-8.78%	3834.63%
Cost of Revenue	629.4	641.8	541.3	599.8	2,995	2,912
Gross Profit	2,058	2,413	2,350	3,324	14,316	16,065
Selling, General & Admin	654.6	624.4	599	557.7	541.2	327.2
Research & Development	2,136	2,105	2,254	1,783	1,537	949.2
Other Operating Expenses	1,102	1,088	811.5	293	410	103.4
Total Operating Expenses	3,892	3,818	3,665	2,634	2,488	1,380
Operating Income	-1,548	-1,405	-1,314	690.4	12,643	15,284
Interest Income	422.4	423.9	664	519.6	330.3	67.7
Interest Expense	-47.6	-69.8	-27.4	-23.9	-18.9	-305.1
Total Non-Operating Income (Expense)	374.8	354.1	636.6	495.7	311.4	-237.4
Pretax Income	-1,174	-1,051	-677.7	1,186	12,954	15,046
Provision for Income Taxes	78.7	85.3	-12.4	255.8	3,520	4,754
Net Income	-1,252	-1,136	-665.3	930.3	9,434	10,293
Net Income to Common	-1,252	-1,136	-665.3	930.3	9,434	10,293
Net Income Growth	-	-	-	-90.14%	-8.34%	67613.82%
Shares Outstanding (Basic)	247	242	240	241	243	244
Shares Outstanding (Diluted)	247	242	240	243	250	260
Shares Change (YoY)	3.18%	0.54%	-0.95%	-2.84%	-3.81%	4.51%
EPS (Basic)	-5.07	-4.70	-2.77	3.87	38.78	42.18
EPS (Diluted)	-5.07	-4.70	-2.77	3.83	37.77	39.63
EPS Growth	-	-	-	-89.86%	-4.69%	65950.00%
Free Cash Flow	632.7	280.9	-78.8	5,122	13,248	762.2
Free Cash Flow Growth	125.24%	-	-	-61.34%	1638.15%	-
Free Cash Flow Per Share	2.56	1.16	-0.33	21.10	53.04	2.93
Gross Margin	76.58%	78.99%	81.28%	84.71%	82.70%	84.66%
Operating Margin	-57.62%	-45.99%	-45.45%	17.59%	73.03%	80.54%
Profit Margin	-46.60%	-37.19%	-23.01%	23.71%	54.50%	54.24%
FCF Margin	23.55%	9.20%	-2.73%	130.53%	76.53%	4.02%
EBITDA	-1,087	-1,022	-1,016	873.8	12,766	15,359
EBITDA Margin	-40.45%	-33.46%	-35.15%	22.27%	73.75%	80.94%
EBIT	-1,548	-1,405	-1,314	690.4	12,643	15,284
EBIT Margin	-57.62%	-45.99%	-45.45%	17.59%	73.03%	80.54%
Effective Tax Rate	-6.71%	-8.12%	1.83%	21.57%	27.17%	31.59%

SEC Filings: 10-K · 10-Q